Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma

SIMPLE SUMMARY: Esophageal adenocarcinoma (EAC) is a cancer with very poor survival outcomes. Patients are treated with pre-operative chemotherapy or chemoradiotherapy before surgery. However, four out of every five patients do not respond to pre-operative therapy and these patients (non-responders)...

Descripción completa

Detalles Bibliográficos
Autores principales: Izadi, Fereshteh, Sharpe, Benjamin P., Breininger, Stella P., Secrier, Maria, Gibson, Jane, Walker, Robert C., Rahman, Saqib, Devonshire, Ginny, Lloyd, Megan A., Walters, Zoë S., Fitzgerald, Rebecca C., Rose-Zerilli, Matthew J. J., Underwood, Tim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308111/
https://www.ncbi.nlm.nih.gov/pubmed/34298611
http://dx.doi.org/10.3390/cancers13143394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308111/
https://www.ncbi.nlm.nih.gov/pubmed/34298611
http://dx.doi.org/10.3390/cancers13143394

Ejemplares similares